FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Saroj Vadhan-Raj

Research Profile

Chemicals & Drugs

Disorders

Physiology

Haematopoiesis

Anatomy

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sean D Raj; Vinod Ravi; Robert S Benjamin; Carlos E Bueso-Ramos; Shreyaskumar Patel; Xiao Zhou; Saroj Vadhan-Raj
Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
Rashmi Kanagal-Shamanna; L Jeffrey Medeiros; Martin H Nguyen; Saroj Vadhan-Raj; Weiqiang Zhao; Michael H Fernandez; Carlos E Bueso-Ramos
Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
Rashmi Kanagal-Shamanna; Gary Lu; L Jeffrey Medeiros; Saroj Vadhan-Raj; Sa Wang; Bedia A Barkoh; Carlos E Bueso-Ramos; Guillermo Garcia-Manero; Daniela Hoehn; C Cameron Yin
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Saroj Vadhan-Raj (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sean D Raj; Vinod Ravi; Robert S Benjamin; Carlos E Bueso-Ramos; Shreyaskumar Patel; Xiao Zhou; Saroj Vadhan-Raj
Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
American journal of clinical oncology 2012;35(5):462-7.
2012: Rashmi Kanagal-Shamanna; L Jeffrey Medeiros; Martin H Nguyen; Saroj Vadhan-Raj; Weiqiang Zhao; Michael H Fernandez; Carlos E Bueso-Ramos
Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
International journal of environmental research and public health 2012;9(8):2788-800.
2012: Rashmi Kanagal-Shamanna; Gary Lu; L Jeffrey Medeiros; Saroj Vadhan-Raj; Sa Wang; Bedia A Barkoh; Carlos E Bueso-Ramos; Guillermo Garcia-Manero; Daniela Hoehn; C Cameron Yin
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
Cancer 2012;118(11):2879-88.
2011: Jeffrey Crawford; Mark L Heaney; Sally Htoy; Susan Hudock; Dwight D Kloth; David J Kuter; Gary H Lyman; Brandon McMahon; David P Steensma; Saroj Vadhan-Raj; Peter Westervelt; Michael Westmoreland; Jeffrey Allen; James Armitage; Douglas W Blayney; Spero R Cataland
Myeloid growth factors.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(8):914-32.
2011: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan-Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1125-32.
2011: Banu K Arun; Daniel Booser; Kristine Broglio; Aman U Buzdar; Kapil Dhinghra; Debbie Frye; Laura Guerra; Nuhad Ibrahim; Shu-Wan Kau; Merrick Ross; Aysegul Sahin; Nour Sneige; Eric Strom; Richard L Theriault; Saroj Vadhan-Raj; Vicente Valero; Ronald Walters; Guosheng Yin; Gabriel N Hortobagyi
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.
The oncologist 2011;16(11):1527-34.
2010: Xiao Zhou; Shyam Teegala; Auris Huen; Yuan Ji; Luis Fayad; Fredrick B Hagemeister; Gregory W Gladish; Saroj Vadhan-Raj
Incidence and risk factors of venous thromboembolic events in lymphoma.
The American journal of medicine 2010;123(10):935-41.
2010: Saroj Vadhan-Raj; Jonathan Trent; Shreyaskumar Patel; Xiao Zhou; Marcella M Johnson; Dejka Araujo; Joseph A Ludwig; Shana O'Roark; Ann M Gillenwater; Carlos Bueso-Ramos; Adel K El-Naggar; Robert S Benjamin
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
Annals of internal medicine 2010;153(6):358-67.
2010: Armen Kasyan; L Jeffrey Medeiros; Zhuang Zuo; Favio P Santos; Farhad Ravandi-Kashani; Roberto Miranda; Saroj Vadhan-Raj; Hartmut Koeppen; Carlos E Bueso-Ramos
Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(8):1113-26.
2010: Saroj Vadhan-Raj
Clinical findings with the first generation of thrombopoietic agents.
Seminars in hematology 2010;47(3):249-57.
2010: Mei Liang; Xin Han; Saroj Vadhan-Raj; Martin Nguyen; Yu H Zhang; Michael Fernandez; Elias Drakos; Sergej Konoplev; C Cameron Yin; Roberto N Miranda; Timothy J McDonnell; L Jeffrey Medeiros; Carlos E Bueso-Ramos
HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(3):381-91.
2010: Saroj Vadhan-Raj; Xiao Zhou; Kurt Sizer; Lincy Lal; Xuemei Wang; Joyce Roquemore; Weiming Shi; Robert S Benjamin; Benjamin Lichtiger
Impact of safety concerns and regulatory changes on the usage of erythropoiesis-stimulating agents and RBC transfusions.
The oncologist 2010;15(12):1359-69.
2009: Weina Chen; Sergej Konoplev; L Jeffrey Medeiros; Hartmut Koeppen; Vasiliki Leventaki; Saroj Vadhan-Raj; Dan Jones; Hagop M Kantarjian; Brunangelo Falini; Carlos E Bueso-Ramos
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.
Cancer 2009;115(23):5481-9.
2009: Hee Chul Park; Nora Janjan; Tito R Mendoza; Edward H Lin; Saroj Vadhan-Raj; Mandeep Hundal; Yiqun Zhang; Marc E Delclos; Christopher H Crane; Prajnan Das; Xin Shelley Wang; Charles S Cleeland; Sunil Krishnan
Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.
International journal of radiation oncology, biology, physics 2009;75(3):775-81.
2009: Ravi Vij; Noemi Horvath; Andrew Spencer; Kerry Taylor; Saroj Vadhan-Raj; Robert Vescio; Judy Smith; Yi Qian; Howard Yeh; Susie Jun
An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma.
American journal of hematology 2009;84(10):650-6.
2009: Kathleen M Schmeler; Saroj Vadhan-Raj; Pedro T Ramirez; Sachin M Apte; Lorenzo Cohen; Roland L Bassett; Revathy B Iyer; Judith K Wolf; Charles L Levenback; David M Gershenson; Ralph S Freedman
A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.
Gynecologic oncology 2009;113(2):210-5.
2009: Dongjiu Ye; Guillermo Garcia-Manero; Hagop M Kantarjian; Lianchun Xiao; Saroj Vadhan-Raj; Michael H Fernandez; Martin H Nguyen; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia.
Journal of hematopathology 2009;2(1):2-8.
2009: Saroj Vadhan-Raj
Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.
Seminars in hematology 2009;46(1 Suppl 2):S26-32.
2009: Jeffrey Crawford; James Armitage; Lodovico Balducci; Charles L Bennett; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; Harry P Erba; James Foran; Alison G Freifeld; Marti Goemann; Mark L Heaney; Sally Htoy; Susan Hudock; Dwight D Kloth; David J Kuter; Gary H Lyman; Laura Boehnke Michaud; Sarah C Miyata; Martin S Tallman; Saroj Vadhan-Raj; Peter Westervelt; Michael K Wong
Myeloid growth factors.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(1):64-83.
2008: David Cella; Hema N Viswanathan; Ron D Hays; Tito R Mendoza; Kevin D Stein; David J Pasta; Aimee J Foreman; Saroj Vadhan-Raj; Joel D Kallich
Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy.
Cancer 2008;113(6):1480-8.
2007: Xiaoping Sun; Wei Zhang; Latha Ramdas; David N Stivers; Daniel M Jones; Hagop M Kantarjian; Elihu H Estey; Saroj Vadhan-Raj; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(8):811-20.
2007: Anjana Bhardwaj; Gautam Sethi; Saroj Vadhan-Raj; Carlos E Bueso-Ramos; Yasunari Takada; Upasna Gaur; Asha S Nair; Shishir Shishodia; Bharat B Aggarwal
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
Blood 2007;109(6):2293-302.
2007: Jeffrey Crawford; Betsy Althaus; James Armitage; Lodovico Balducci; Charles L Bennett; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; Harry P Erba; James Foran; Alison G Freifeld; Mark L Heaney; Sally Htoy; Dwight D Kloth; Gary H Lyman; Wells A Messersmith; Laura Boehnke Michaud; Sarah C Miyata; Amy Robbins; Martin S Tallman; Saroj Vadhan-Raj; Peter Westervelt; Michael K Wong
Myeloid growth factors. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(2):188-202.
2006: Weiqiang Zhao; David F Claxton; L Jeffrey Medeiros; Di Lu; Saroj Vadhan-Raj; Hagop M Kantarjian; Martin H Nguyen; Carlos E Bueso-Ramos
Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
The American journal of surgical pathology 2006;30(11):1436-44.
2006: Sunil Krishnan; Nora Janjan; John M Skibber; Miguel A Rodriguez-Bigas; Robert A Wolff; Prajnan Das; Marc E Delclos; George J Chang; Paulo M Hoff; Cathy Eng; Thomas D Brown; Christopher H Crane; Barry W Feig; Jeffrey Morris; Saroj Vadhan-Raj; Stanley R Hamilton; Edward H Lin
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2006;66(3):762-71.
2006: Malisha R Johnson; Daniel Del Carpio-Jayo; Pei Lin; Sergio Giralt; Paolo Anderlini; Richard E Champlin; Issa F Khouri; Saroj Vadhan-Raj; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Annals of diagnostic pathology 2006;10(5):263-8.
2006: Mihai Merzianu; Liuyan Jiang; Pei Lin; Xuemei Wang; Donna M Weber; Saroj Vadhan-Raj; Martin H Nguyen; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(7):891-8.
2006: John Glaspy; Saroj Vadhan-Raj; Ravi Patel; Linda Bosserman; Eddie Hu; Richard E Lloyd; Ralph V Boccia; Dianne Tomita; Greg Rossi
Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2290-7.
2006: Jorge Chaves; Auris Huen; Carlos E Bueso-Ramos; Amar Safdar; Saroj Vadhan-Raj
Aerosolized ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(8):e72-5.
2006: Sachin M Apte; Saroj Vadhan-Raj; Lorenzo Cohen; Roland L Bassett; Ilyssa O Gordon; Charles Levenback; Pedro T Ramirez; Stacie T Gallardo; Rebecca Patenia; Michael E Garcia; Revathy B Iyer; Ralph S Freedman
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.
Journal of translational medicine 2006;4():16.
2005: Jeffrey Crawford; Betsy Althaus; James Armitage; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; James Foran; Mark L Heaney; Sally Htoy; Dwight D Kloth; Gary H Lyman; Laura Boehnke Michaud; Susannah Motl; Saroj Vadhan-Raj; Michael K Wong
Myeloid growth factors clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):540-55.
2005: Saroj Vadhan-Raj; Victor Cohen; Carlos E Bueso-Ramos
Thrombopoietic growth factors and cytokines.
Current hematology reports 2005;4(2):137-44.
2004: Carlos E Bueso-Ramos; Frederico C Rocha; Shishir Shishodia; L Jeffrey Medeiros; Hagop M Kantarjian; Saroj Vadhan-Raj; Zeev Estrov; Terry L Smith; Martin H Nguyen; Bharat B Aggarwal
Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.
Human pathology 2004;35(2):246-53.
2003: Ralph S Freedman; Saroj Vadhan-Raj; Cherie Butts; Cherylyn A Savary; Bohuslav Melichar; Claire F Verschraegen; John J Kavanagh; Marshall E Hicks; Lawrence B Levy; Jody Folloder; Michael E Garcia
Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5228-37.
2003: Saroj Vadhan-Raj; Shreyaskumar Patel; Carlos E Bueso-Ramos; Jody Folloder; Nicholas Papadopolous; Andrew Burgess; Lyle D Broemeling; Hal E Broxmeyer; Robert S Benjamin
Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3158-67.
2003: Saroj Vadhan-Raj; Barry Mirtsching; Veena Charu; Dixon Terry; Gregory Rossi; Dianne Tomita; William P McGuire
Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.
The journal of supportive oncology 2003;1(2):131-8.
2003: Linda S Elting; Scott B Cantor; Charles G Martin; Lois Hamblin; Danna Kurtin; Edgardo Rivera; Saroj Vadhan-Raj; Robert S Benjamin
Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors.
Cancer 2003;97(6):1541-50.
2003: Saroj Vadhan-Raj
Future directions with hematopoietic growth factors.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1 Suppl 1():S96-101.
2002: Barry Mirtsching; Veena Charu; Saroj Vadhan-Raj; Alan B Colowick; Gregory Rossi; Dianne Tomita; William P McGuire
Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
Oncology (Williston Park, N.Y.) 2002;16(10 Suppl 11):31-6.
2002: Saroj Vadhan-Raj; John J Kavanagh; Ralph S Freedman; Jody Folloder; Laura M Currie; Carlos E Bueso-Ramos; Claire F Verschraegen; Aida Narvios; Jerome Connor; W Keith Hoots; Lyle D Broemeling; Benjamin Lichtiger
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Lancet 2002;359(9324):2145-52.
2002: Linda S Elting; Charles G Martin; Danna Kurtin; Scott B Cantor; Edward B Rubenstein; Saul Rodriguez; Krishnakumari Kanesan; Saroj Vadhan-Raj; Robert S Benjamin
The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
Cancer 2002;94(12):3252-62.
2001: Saroj Vadhan-Raj
Recombinant human thrombopoietin in myelosuppressive chemotherapy.
Oncology (Williston Park, N.Y.) 2001;15(7 Suppl 8):35-8.
2001: Monica Grazziutti; Donna Przepiorka; John H Rex; Ira Braunschweig; Saroj Vadhan-Raj; Cherylyn A Savary
Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus.
Bone marrow transplantation 2001;27(6):647-52.
2000: Saroj Vadhan-Raj
Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.
Seminars in hematology 2000;37(2 Suppl 4):28-34.
2000: Saroj Vadhan-Raj; Claire F Verschraegen; Carlos E Bueso-Ramos; Hal E Broxmeyer; A P Kudelkà; Ralph S Freedman; Creighton L Edwards; David M Gershenson; Denny Jones; Mark Ashby; John J Kavanagh
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Annals of internal medicine 2000;132(5):364-8.
1999: Saroj Vadhan-Raj; Laura M Currie; Carlos E Bueso-Ramos; SA Livesey; Jerome Connor
Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution (ThromboSol) and 2% DMSO.
British journal of haematology 1999;104(2):403-11.
1998: DM Prow; Saroj Vadhan-Raj
Thrombopoietin: biology and potential clinical applications.
Oncology (Williston Park, N.Y.) 1998;12(11):1597-604, 1607-8; discussion 1611-4.
1998: M Benjapibal; Andrzej P Kudelka; A Vasuratna; Creighton L Edwards; Claire F Verschraegen; V Valero; Saroj Vadhan-Raj; John J Kavanagh
Docetaxel and cyclophosphamide induced remission in platinum and paclitaxel refractory ovarian cancer.
Anti-cancer drugs 1998;9(6):577-9.
1998: Saroj Vadhan-Raj
Recombinant human thrombopoietin: clinical experience and in vivo biology.
Seminars in hematology 1998;35(3):261-8.
1998: Shreyaskumar R Patel; Saroj Vadhan-Raj; Michael A Burgess; Carl Plager; Nicholas Papadopolous; Jan Jenkins; Robert S Benjamin
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.
American journal of clinical oncology 1998;21(3):317-21.
1998: Lesley J Murray; KM Luens; M F Estrada; E Bruno; Ronald Hoffman; R L Cohen; M A Ashby; Saroj Vadhan-Raj
Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Experimental hematology 1998;26(3):207-16.
1998: Bonnie S Glisson; Ritsuko Komaki; Jin S Lee; Dong M Shin; Frank V Fossella; WK Murphy; Jonathan M Kurie; Roman Perez-Soler; RA Schea; Saroj Vadhan-Raj
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
International journal of radiation oncology, biology, physics 1998;40(2):331-6.
1998: Dennie V Jones; Mark Ashby; Saroj Vadhan-Raj; George Somlo; Richard Champlin; James L Gajewski; Sue Hellmann; Gwen Fyfe
Recombinant human thrombopoietin clinical development.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():199-206.
1997: Shreyaskumar R Patel; Saroj Vadhan-Raj; Nicholas Papadopolous; Carl Plager; Michael A Burgess; C Hays; Robert S Benjamin
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2378-84.
1997: Saroj Vadhan-Raj; Lesley J Murray; Carlos E Bueso-Ramos; Shreyaskumar Patel; Sekhar M Pothireddy; W Keith Hoots; T Johnston; Nicholas Papadopolous; W N Hittelman; DA Johnston; T A Yang; V E Paton; R L Cohen; Sue Hellmann; Robert S Benjamin; Hal E Broxmeyer
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.
Annals of internal medicine 1997;126(9):673-81.
1997: John Glaspy; R Bukowski; D Steinberg; C Taylor; Simon Tchekmedyian; Saroj Vadhan-Raj
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1218-34.
1997: Sekhar M Pothireddy; R M Harwood; D F Moore; Elizabeth A Grimm; James L Murray; Saroj Vadhan-Raj
Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: a phase 1 study.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(1):79-87.
1995: Saroj Vadhan-Raj; H E Broxmeyer; Michael Andreeff; J C Bandres; E Stephen Buescher; Robert S Benjamin; Nicholas E Papadopoulos; A Burgess; Shreyaskumar Patel; Carl Plager; Walter N Hittelman; I McAlister; L Garrison; D E Williams
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.
Blood 1995;86(6):2098-105.
1994: D F Moore; S Buescher; Saroj Vadhan-Raj
Interleukin-1 alpha administration increases oral granulocytes and epithelial cells.
The Journal of infectious diseases 1994;169(6):1419-20.
1994: Saroj Vadhan-Raj
PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
Stem cells (Dayton, Ohio) 1994;12(3):253-61.
1994: Saroj Vadhan-Raj; Nicholas E Papadopoulos; Michael A Burgess; K A Linke; Shreyaskumar R Patel; C Hays; A Arcenas; Carl Plager; Andrzej P Kudelka; Walter N Hittelman
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):715-24.
1994: Saroj Vadhan-Raj; Andrzej P Kudelka; L Garrison; Jacalyn B Gano; Creighton L Edwards; Ralph S Freedman; John J Kavanagh
Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):707-14.
1993: A M Lee; Saroj Vadhan-Raj; Raymond F Hamilton; R K Scheule; Andrij Holian
The in vivo effects of rhIL-1 alpha therapy on human monocyte activity.
Journal of leukocyte biology 1993;54(4):314-21.
1993: E Stephen Buescher; S M McIlheran; S M Banks; Saroj Vadhan-Raj
The effects of treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on human polymorphonuclear leukocyte function.
Experimental hematology 1993;21(11):1467-72.
1993: R C Perkins; Saroj Vadhan-Raj; R K Scheule; R Hamilton; Andrij Holian
Effects of continuous high dose rhGM-CSF infusion on human monocyte activity.
American journal of hematology 1993;43(4):279-85.
1993: E Stephen Buescher; S M McIlheran; S M Banks; A P Kudelka; J J Kavanagh; Saroj Vadhan-Raj
The effects of interleukin-1 therapy on peripheral blood granulocyte function in humans.
Cancer immunology, immunotherapy : CII 1993;37(1):26-30.
1993: Raymond F Hamilton; Saroj Vadhan-Raj; M Uthman; M Grey; Andrij Holian
The in vivo effects of PIXY321 therapy on human monocyte activity.
Journal of leukocyte biology 1993;53(6):640-50.
1993: A G Arcenas; Saroj Vadhan-Raj
Hematopoietic growth factor therapy of myelodysplastic syndromes.
Leukemia & lymphoma 1993;11 Suppl 2():65-9.
1992: Saroj Vadhan-Raj; H E Broxmeyer; Walter N Hittelman
Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
Seminars in hematology 1992;29(4 Suppl 3):4-13.
1992: Saroj Vadhan-Raj; H E Broxmeyer; Walter N Hittelman; Nicholas E Papadopoulos; S P Chawla; C Fenoglio; S Cooper; E Stephen Buescher; R W Frenck; A Holian
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1266-77.
1992: Saroj Vadhan-Raj
Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia.
Immunology series 1992;57():661-70.
1990: G J Ventura; Jeane Hester; E Stephen Buescher; Saroj Vadhan-Raj; A Durrett; C L Reading
Hematopoiesis in limiting dilution cultures: influence of cytokines on human hematopoietic progenitor cells.
Experimental hematology 1990;18(8):878-82.
1990: E Stephen Buescher; S M McIlheran; S M Banks; Saroj Vadhan-Raj
Alteration of the functional effects of granulocyte-macrophage colony-stimulating factor on polymorphonuclear leukocytes by membrane-fluidizing agents.
Infection and immunity 1990;58(9):3002-8.
1990: Walter N Hittelman; J D Tigaud; Elihu Estey; Saroj Vadhan-Raj
Premature chromosome condensation in the study of minimal residual disease.
Bone marrow transplantation 1990;6 Suppl 1():9-13.
1990: Jordan U Gutterman; Saroj Vadhan-Raj; C Logothetis; E Anaissle; Elihu Estey; Moshe Talpaz; Razelle Kurzrock
Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense.
Seminars in hematology 1990;27(3 Suppl 3):15-24.
1990: Saroj Vadhan-Raj; W N Hittelman; J L Lepe-Zuniga; Jordan U Gutterman; H E Broxmeyer
Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes.
Blood 1990;75(8):1749-50.
1990: Saroj Vadhan-Raj; W S Velasquez; J J Butler; A LeMaistre; J Lepe-Zuniga; Michael J Keating; Charles Koller; Jordan U Gutterman
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor.
American journal of hematology 1990;33(3):189-97.
1990: Saroj Vadhan-Raj; Sima Jeha; S Buescher; A LeMaistre; G Yee; L Lu; J Lloreta; W Keith Hoots; Walter N Hittelman; Jordan U Gutterman
Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1990;75(4):858-64.
1990: G J Ventura; C L Reading; Jeane Hester; Saroj Vadhan-Raj
Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration.
Acta haematologica 1990;84(4):175-81.
1989: Saroj Vadhan-Raj; H E Broxmeyer; G Spitzer; A LeMaistre; S Hultman; G Ventura; J D Tigaud; M A Cork; J M Trujillo; Jordan U Gutterman
Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome.
Blood 1989;74(5):1491-8.
1989: R W Frenck; E Stephen Buescher; Saroj Vadhan-Raj
The effects of recombinant human granulocyte-macrophage colony stimulating factor on in vitro cord blood granulocyte function.
Pediatric research 1989;26(1):43-8.
1989: G J Ventura; Jeane Hester; F Swan; Saroj Vadhan-Raj; J Turpin; K A Dicke; C L Reading
Analysis of peripheral blood granulocyte-macrophage colony growth by limiting dilution assay.
Experimental hematology 1989;17(2):125-9.
1989: Saroj Vadhan-Raj; Walter N Hittelman; H E Broxmeyer; Michael Keating; D Urdal; Jordan U Gutterman
In vivo biologic activities of recombinant human granulocyte-macrophage colony-stimulating factor.
Annals of the New York Academy of Sciences 1989;554():231-40.
1988: Saroj Vadhan-Raj; S Buescher; H E Broxmeyer; A LeMaistre; J L Lepe-Zuniga; G Ventura; Sima Jeha; L J Horwitz; J M Trujillo; S Gillis
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
The New England journal of medicine 1988;319(25):1628-34.
1988: E Stephen Buescher; S M McIlheran; Saroj Vadhan-Raj
Effects of in vivo administration of recombinant human granulocyte-macrophage colony-stimulating factor on human neutrophil chemotaxis and oxygen metabolism.
The Journal of infectious diseases 1988;158(5):1140-2.
1988: Saroj Vadhan-Raj; M J Kellagher; M Keating; R Walters; Jordan U Gutterman
Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancy.
Behring Institute Mitteilungen 1988;(83):119-24.
1988: Saroj Vadhan-Raj; S Buescher; A LeMaistre; Michael Keating; R Walters; C Ventura; Walter N Hittelman; H E Broxmeyer; Jordan U Gutterman
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1988;72(1):134-41.
1987: Saroj Vadhan-Raj; Michael Keating; A LeMaistre; Walter N Hittelman; K McCredie; J M Trujillo; H E Broxmeyer; C Henney; Jordan U Gutterman
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
The New England journal of medicine 1987;317(25):1545-52.